NCT01910415View on ClinicalTrials.gov

Phase 1, QT/QTC Interval Study in Healthy Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

200

Participants

Timeline

Start Date

June 30, 2013

Primary Completion Date

March 31, 2014

Study Completion Date

March 31, 2014

Conditions
Cystic Fibrosis
Interventions
DRUG

Lumacaftor

DRUG

Lumacaftor Placebo

DRUG

Ivacaftor

DRUG

Ivacaftor Placebo

DRUG

moxifloxacin hydrochloride

Trial Locations (1)

Unknown

Zuidlaren

All Listed Sponsors
lead

Vertex Pharmaceuticals Incorporated

INDUSTRY

NCT01910415 - Phase 1, QT/QTC Interval Study in Healthy Subjects | Biotech Hunter | Biotech Hunter